Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 32c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 32c

Castle Biosciences Announces Second Quarter 2020 Results

August 10, 2020 4:05 PM EDT

Q2 2020 revenues of $12.7 million, compared to $10.7 million in Q2 2019
DecisionDx-Melanoma test report volume decreased 19% compared to Q2 2019
Gross margin of 83%
Positive operating cash flow

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its financial results for the second quarter and six months ended June 30, 2020.

While our second quarter financial results reflect COVID-19 impacts, thanks to the strong execution by our employees, we continue to successfully... More